512 — Grand Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$15.09bn
- HK$19.44bn
- HK$12.28bn
Brief: Grand Pharmaceutical Says Ophthalmic Drug GPN00884 Approved For Phase I Clinical Study In China
Brief: Grand Pharmaceutical Announces Facility Agreement
Brief: Grand Pharmaceutical Says NDA Of Ryaltris Submitted To Nmpa Accepted
Brief: Grand Pharmaceutical Says Investigational New Drug Application Of Tumor Vaccine Arc01 Approved By Nmpa
Brief: Grand Pharmaceutical Says Acquisition Of Stake In Chongqing Duoputai Pharmaceutical Technology
Brief: Grand Pharmaceutical Group Says Investigational New Drug Application Of GPN00884 Was Accepted By China's NMPA
Brief: Grand Pharmaceutical Says Group Acquires Controlling Equity Interest In Tianjin Tanabe
Brief: Grand Pharmaceutical Group Ltd Says Distribution Agreement With Sirtex Medical
Brief: Grand Pharmaceutical Group Enters Into An Equity Investment Agreement
Brief: Grand Pharmaceutical's Innovative Therapeutic Tumor Vaccine Arc01 Was Accepted By NMPA Of China
Brief: Grand Pharmaceutical Says Phase III Clinical Study Of Ryaltris® Compound Nasal Spray Completed
Brief: Grand Pharmaceutical Says Carglumic Acid Dispersible Tablets Granted Drug Registration Certificate
Brief: Grand Pharmaceutical Group Says Unit Entered Into Convertible Loan Deal With Sirtex Holdco
Brief: Grand Pharmaceutical Group Posts HY Net Profit HK$1,029.35 Million
Brief: Grand Pharmaceutical Says New MRA Drug Eplerenone Tablets Granted Drug Registration Certificate
Brief: Grand Pharmaceutical Says STC3141 Approved By NMPA To Conduct Phase II Clinical Study In China
Brief: Grand Pharmaceutical Says Niu Zhanqi Resigned As Executive Director
Brief: Grand Pharmaceutical Says Application Of Phase II Clinical Study Of STC3141 Accepted By NMPA
Grand Pharma jumps after saying unit's fine not affecting operation